Correlation Between Eliem Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Eliem Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Reviva Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eliem and Reviva is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.98 times more return on investment than Reviva Pharmaceuticals. However, Eliem Therapeutics is 1.02 times less risky than Reviva Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.0 per unit of risk. If you would invest 285.00 in Eliem Therapeutics on September 3, 2024 and sell it today you would earn a total of 19.00 from holding Eliem Therapeutics or generate 6.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Eliem Therapeutics |
| Reviva Pharmaceuticals |
Eliem Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |